Streetbeat News

Analyst Ratings

RCUS

Arcus Biosciences (NYSE:RCUS) has been evaluated by 4 analysts over the last three months, showing a shift towards a more cautious stance with a decrease in the average 12-month price target from $43.50 to $34.5, indicating a 20.69% decrease. The company, a clinical-stage biopharmaceutical firm focusing on cancer immunotherapies, faces revenue challenges with a -3.03% decline as of September 30, 2023, but maintains a strong market presence through its market capitalization and a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

February 22, 2024 | 2:00 pm

CALT

HC Wainwright & Co. analyst Arthur He reiterates a Buy rating on Calliditas Therapeutics (NASDAQ:CALT) and maintains a $50 price target.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 1:53 pm

LCID

Lucid Group Inc (NASDAQ:LCID) shares fell after reporting Q4 revenue of $157.2 million, missing estimates of $179.88 million, but beating EPS estimates with a loss of 29 cents per share. The company produced 2,391 vehicles and delivered 1,734 in Q4, ending with $4.78 billion in liquidity. Lucid aims for 9,000 vehicle production in the full year and confirmed production timelines for its Gravity SUV and a midsize platform. Following the results, Cantor Fitzgerald downgraded Lucid from Neutral to Underweight, reducing the price target from $6 to $4.

Portfolio Pulse from Adam Eckert

February 22, 2024 | 1:52 pm

TNK

Jefferies analyst Omar Nokta has reiterated a Buy rating on Teekay Tankers (NYSE:TNK) and maintained a $70 price target on the stock.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 1:50 pm

HRMY

Needham analyst Ami Fadia reiterated a Buy rating on Harmony Biosciences (NASDAQ:HRMY) and maintained a $53 price target.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 1:47 pm

MTTR

Wedbush analyst Daniel Ives maintains a Neutral rating on Matterport (NASDAQ:MTTR) and lowers the price target from $5 to $4.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 1:45 pm

DTE

NEE

SRE

Wall Street's most accurate analysts have provided their views on three utilities stocks with over 3% dividend yields: Sempra (SRE), NextEra Energy (NEE), and DTE Energy (DTE). These stocks are highlighted for their high dividend yields and recent analyst ratings, including upgrades, downgrades, and price target adjustments. Sempra will report Q4 earnings on Feb. 27, 2024, while NextEra Energy and DTE Energy have posted better-than-expected quarterly results.

Portfolio Pulse from Avi Kapoor

February 22, 2024 | 1:42 pm

BYON

Wedbush analyst Michael Pachter maintains an Outperform rating on Beyond (NYSE:BYON) and raises the price target from $33 to $35.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 1:40 pm

ETSY

Wedbush analyst Seth Basham maintains a Neutral rating on Etsy (NASDAQ:ETSY) and lowers the price target from $85 to $80.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 1:37 pm

NVDA

Wedbush analyst Matt Bryson maintains an Outperform rating on NVIDIA (NASDAQ:NVDA) and raises the price target from $800 to $850.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 1:31 pm